This Article Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article link to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Errata

On 231, the target protein for ATRA should read, "...the fusion PML-RAR protein."

In the next to last paragraph, because STI571 induces programmed cell death, it should read, "Since the bcr-abl protein is anti-apoptotic, while the drug is pro-apoptotic, ..."

TAXANE/ANTHRACYCLINE COMBINATIONS: SETTING A NEW STANDARD IN BREAST CANCER?

The Oncologist 2001; 6(suppl 3): 5–12

On 8, in the second paragraph from the bottom under Randomized Phase III Trials of Paclitaxel Plus Doxorubicin in MBC, doxorubicin was erroneously called docetaxel: "... or a combination of 50 mg/m² docetaxel and 150 mg/m² paclitaxel, again over 24 hours" should be "or a combination of 50 mg/m² doxorubicin and 150 mg/m² paclitaxel, again over 24 hours."

This Article Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article link to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content